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Abstract: Aim: This study want to demonstrate the efficaciousness of drotaverinum as a 
replacer of papaverine in the prevention and treatment of vasospasm. Material and 
method: In this study were used 20 albino Wistar male rats. Rats were divided in two 
groups and vasospasm was induced to the both femoral artery and after that irrigation 
of the femoral arteries with drotaverinum was performed to demonstrate the 
vasodilatation that can appear (group A). In the group B after the obtaining of vasospasm 
irrigation of the femoral arteries with saline solution was performed and this group was 
used as witness. The length of the vessels was measured when was achieved the 
vasospasm and also before and after the administration of the solutions. Pictures were 
taken at every step of dissection and solutions administration to can measure the length 
of arteries before and after the administration of drotaverinum and the saline solution. 
Results: In all rats was obtained vasospasm at the femoral artery after clipping the artery 
and after we irrigate with adrenaline. In the group with drotaverinum we obtained the 
vasodilatation and in the witness group the caliber of the vessels remain the same. The 
statistical analysis of the data demonstrate a significant differences between the group 
were was used drotaverinum and the witness group were was used the saline solution 
(p<0,001). Conclusions: Drotaverinum has a good vasodilatative effect on arteries and he 
can prevent the apparition of vasospasm and it can even treat vasospasm if occur by 
producing local vasodilatation and a good circulation in the area where is administrated. 
This study showed quantitatively that drotaverinum can treat the experimental 
peripheral vasospasm in rats. 
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Introduction 
Cerebral vasospasm can occur after 
subarachnoidian hemorrhage and is one of the 
leading causes of morbidity and mortality in 
this type of pathology (1-3). Subarachnoidian 
hemorrhage represent the bleeding in the 
subarachnoidian space and the most frequent 
pathology that can determine that bleeding are 
the ruptured aneurysms (4). 
Cerebral vasospasm after subarachnoidian 
hemorrhage represent a challenge problem 
from the prevention and treatment point of 
view and contributes to the most devastating 
injury: delayed cerebral ischemia (2, 5, 6). 
When delayed cerebral ischemia occur the 
patient outcome is poor and this can lead even 
to death (6). 
The objective of our study was to 
demonstrate on rats models the benefits of 
drotaverinum when is applied on a spastic 
artery and to demonstrate the efficacy instead 
of papaverine. Also intraoperatory cisternal 
irrigation with drotaverinum of the arteries 
after the aneurysm is clipped is performed to 
prevent the apparition of the vasospasm or 
even to treat this if already has developed.  In 
our statistics the incidence of cerebral 
vasospasm is lower than the data from the 
literature and we thought that is happening 
because of the use of drotaverinum. 
In the literature are studies about cisternal 
irrigation after clipping the aneurysm but with 
papaverine not with drotaverine (7). In 
literature are studies about the resistance 
against intra-arterial papaverine in cerebral 
vasospasm or about the efficacy of papaverine 
in this type of pathology but about 
drotaverinum there’s no study to see if is a good 
option to use it instead of papaverine (8, 9). 
Materials and methods 
Animals and housing  
Twenty (n=20) male HsdOla:WI rats 
weighing between 300 and 350 grams were 
used in the present study. The animals were 
housed in polysulfone type III open-top cages 
(Tecniplast, Italy) and had access to filtered tap 
water in bottles and peletted feed (Nutret 
combinat granulat, Cantacuzino Institute, 
Romania) ad libitum. The rats were kept in the 
Laboratory Animal Facility of the „Iuliu 
Hatieganu” University of Medicine and 
Pharmacy at a standard temperature of 24 ± 2 
°C, a relative humidity of 55 ± 10%, 12:12-h 
light:dark cycle (lights on, 0700 to 1900). All 
experimental protocols were approved by the 
Ethics Comittee of the University (no. 
301/29.05.2015 ) and were conducted in 
accordance the EU Directive 63/2010, as per 
which, the experimental procedure severity 
was classified as moderate, as the animals fully 
recovered and were not sacrificed after the 
procedure. 
Experimental procedure 
The animals were randomly assigned into 
two (n=2) groups of ten (n=10) individuals per 
group. Group A was used to assess the 
efficiency of drotaverinum for preventing the 
occurrence of vasospasm, while group B was 
used as a control group. The rats were 
anesthetized by a intramuscular injection of a 
Xylazine:Ketamine cocktail in a dosage of 8 
mg/kg Xylazine to 80 mg/kg Ketamine. After 
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anesthesia, the animals were positioned in a 
dorsal decubitus. 
After positioning the rats was performed 
shaving the medial part of the posterior legs 
and was make a skin incision about 2 cm and 
dissect the anatomical structures till was 
discovered the femoral artery and of course the 
femoral vein and sciatic nerve in the medial 
and respectively lateral side of artery. The 
dissection was continued till the femoral artery 
was isolated (figure 1). After the preparation of 
the femoral artery a vascular clip was put 
(figure 2) and maintained it for 2 minutes and 
at the same time the artery was irrigated with 
adrenaline (0,1 ml with concentration of 
1/1000). After 2 minutes the clip was removed 
and the narrowing of the lumens artery was 
obtained (figure 3). When the experimental 
vasospasm was obtained the irrigation of the 
femoral artery with drotaverinum (0,1 ml) was 
performed and after another 2 minutes the 
vessel was dilated (figure 4). This protocol was 
applied for all the 10 animal models from the 
group A and the experiment was made on the 
both posterior legs. 
In the witness group was used the same 
protocol as was mentioned above with the 
exception that the irrigation of the femoral 
artery, after the experimental vasospasm, was 
made with saline solution not with 
drotaverinum. In this group was observed that 
the saline solution does not produce 
vasodilatation and the vessels remains 
narrowed were was put the vascular clip. 
The dissections were performed with 
microsurgical instruments under the 
microscope (Leika). Each step of the study 
protocol with the femoral artery was 
photographed. After finishing the study 
measurements on arteries after clipping, after 
tamponing with drotaverinum and with saline 
solution was achieved. The measurements 
were performed with a special soft of 
morphometry (Axiovision Rel 4.6.) (figures 5 
and 6). 
After the experimental study the animal 
models were observed till 7 days to see if they 
develop some complications after the 
vasospasm that was induced. In group A 
doesn’t occur any complication due to 
vasospasm, but in the group B occurred 2 
posterior limb ischemia that maybe was 
produced by the narrowing of the femural 
artery. 
The statistical analysis was performed 
using MedCalc soft. The statistical tests which 
were applied were T-test and correlation 
coefficient that will be shown in the results. 
 
 
Figure 1 - Femoral artery of the right posterior limb 
and its relationship with the sciatic and femoral vein 
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Figure 2 - The vascular clip on the femoral artery 
 
 
Figure 3 - We can observe the experimental 
vasospasm obtained on femoral artery that appeared 
after clipping and irrigate the artery with adrenaline 
 
Figure 4 - The dilated artery after the irrigation with 
drotaverinum 
 
 
Figure 5 - Measurement of the femoral artery after 
clipping and irrigation with adrenaline 
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Figure 6 - Measurement of the femoral artery after 
irrigation with drotaverinum 
 
 
Graph no.1 The diameter of the vessel is depicted 
before and after the irrigation of the arteries with 
drotaverinum 
 
 
Figure 7 - Data platted for group A and B. Error bars drown at the 95% confidence interval. Red points 
representing the means 
 
Results 
After the dissections and the 
measurements that were performed on the 
femoral arteries we analyzed all the data using 
MedCalc soft. 
The first statistical tests was applied to see 
if there is a significant difference between 
group A were was used the drotaverinum and 
the group B were was not administrated the 
drotaverinum. After the statistical analysis we 
obtained a significant difference between the 
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two groups with p<0,0001 and that suggest the 
benefits of the irrigation with drotaverinum 
when  vasospasm is occurred. 
In Graph no.1 the diameter of the vessel is 
depicted before and after the irrigation of the 
arteries with drotaverinum. The mean of the 
vessels before irrigation with drotaverinum 
was 37,66 and after the administration of 
drotaverinum the mean was 56,97. The 
statistical analysis depicted a significant 
difference between the two means (p<0,05). 
Statistical tests in the group B were applied 
before and after the irrigation with saline 
solution. The mean before irrigation was 45,44 
and after irrigation with saline solution the 
mean was 44,23. In this group we observe the 
saline solution has no effect on the vessels. 
Between the two groups there was no 
differences in the diameter of the vessels 
before the irrigation with drotaverinum or 
with the saline solution and the standard 
deviation was 7,83±1,75. 
After the irrigation with drotaverinum in 
the group A and the irrigation with saline 
solution the group B the mean of the vessels 
diameter in the first group was 52,02 and in the 
group B the mean was 44,23. The statistical 
analysis depicted a significant difference 
between the two means (p<0,001). 
All the data were analyzed and we obtained 
a statistically significant difference between 
the two groups after the irrigation with 
drotaverinum (p<0,001) with a standard 
deviation 13,76±3,07. 
In figure 7 we can see the data platted for 
group A and B. The red points represent the 
means. p<0.001. 
Discussion 
Cerebral vasospasm is a difficult 
pathological entity to treat or to deal with it 
and also in the literature are a lot of studies and 
trials about the controversies concerning the 
prevention and the treatment of the cerebral 
vasospasm that can occur after 
subarachnoidian hemorrhage (10-13).   
Cerebral vasospasm after subarahnoidian 
hemorrhage produced by ruptured aneurysms 
remains still a very controversial topic (14). 
Cerebral vasospasm represent the leading cause 
of mortality and morbidity in subarachnoidian 
hemorrhage and can lead to delayed cerebral 
ischemia (1, 2). In the treatment of cerebral 
vasospasm the only medication that was proven 
to reduce delayed cerebral ischemia is the 
nimodinipine (1, 15-17). 
About 30% of patients who suffered 
nontraumatic subarachnoidian hemorrhage 
develop cerebral vasospasm and secondary to 
this they develop ischemia (10). Cerebral 
vasospasm occur often in the third day after 
the hemorrhage and in the day 5 to 7 riches the 
maximum (11). 
In the treatment of cerebral vasospasm are 
included the triple H therapy (hypertension, 
hypervolemia, hemodilution), balloon 
angioplasty, intra-arterial vasodilatators, 
administration of substances like statins, 
endothelina-1 antagonists and magnesium 
sulfate (2, 5, 11). 
Conclusions 
Our study demonstrate the importance of 
using the drotaverinum after the vasospasm 
occurrence and is very important to perform 
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irrigation with drotaverinum on the cerebral 
arteries after clipping the aneurysm because 
this will prevent the occurrence of  vasospasm 
or will treat it if occurred. 
Drotaverinum has no complication if we 
use it to irrigate the cerebral arteries and the 
vasodilatation that appears after using 
drotaverinum is useful because is achieved a 
better blood circulation in the area and 
prevent the ischemia occurrence. 
In our opinion after the aneurysm is 
clipped the irrigation of the vessels, 
surrounding the aneurysm, with 
drotaverinum can decrease the incidence of 
vasospasm. Also if, intraoperative, we find a 
visible vasospasm the irrigation of the arteries 
with drotaverinum will help the vessel to dilate 
and to return to optimal caliber for the blood 
flow. 
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